EPAS1 and nonpapillary renal cell carcinoma: OSRC2 and TUHR4TKB renal carcinoma cell lines are examples of pVHL-defective ccRCC lines that display a proliferative disadvantage after CRISPR-mediated inactivation of EPAS1 in competition assays carried out over weeks in vitro (21, 24).